Gould Capital, LLC - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 246 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 3.30 and the average weighting 0.1%.

Quarter-by-quarter ownership
Gould Capital, LLC ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$13,145
+18.2%
5000.0%0.01%
+22.2%
Q2 2023$11,125
+2.7%
5000.0%0.01%
+12.5%
Q1 2023$10,830
+6.6%
5000.0%0.01%0.0%
Q4 2022$10,155
-21.9%
5000.0%0.01%
-27.3%
Q3 2022$13,000
+8.3%
5000.0%0.01%
+10.0%
Q2 2022$12,000
+9.1%
5000.0%0.01%
+25.0%
Q1 2022$11,000
+10.0%
5000.0%0.01%
+14.3%
Q4 2021$10,0005000.01%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,609,429$55,961,0003.12%
INVESTOR AB 1,835,974$11,934,0000.86%
GLOBEFLEX CAPITAL L P 244,183$1,587,0000.40%
Campbell & CO Investment Adviser LLC 21,446$139,0000.37%
Birchview Capital, LP 80,000$520,0000.30%
FEDERATED HERMES, INC. 13,879,968$90,220,0000.26%
MENTA CAPITAL LLC 388,582$2,526,0000.24%
Sitrin Capital Management LLC 40,000$260,0000.20%
ESSEX INVESTMENT MANAGEMENT CO LLC 172,389$1,121,0000.18%
GSA CAPITAL PARTNERS LLP 384,976$2,502,0000.13%
View complete list of CORCEPT THERAPEUTICS INC shareholders